Related posts:
- Current state of evidence on “off label” therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria, and Switzerland – a consensus report
- Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report
- Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus.
- Mycophenolate mofetil inducing remission of lupus enteritis